Priceop.com : la roche-posay effaclar a.z. gel cream cream gel against imperfections in acne-prone skin 40 ml Priceop.com : la roche-posay effaclar a.z. gel cream cream gel against imperfections in acne-prone skin 40 ml
¤29.60
La Roche-Posay Effaclar A.Z. Gel Cream, 40 ml, Local Treatment unisex, Imperfection-free skin thanks to light treatment with a trio of active acids Perfectly balanced care for skin that craves a flawless appearance and hydration. La Roche-Posay Effaclar A.Z. Gel Cream combines the power of azelaic acid and salicylic acid to reduce pimples, even skin tone and soften skin texture. The light gel texture is immediately absorbed and visibly brightens and smooths skin in just 7 days. Hyaluronic acid provides long lasting hydration that will leave your skin looking healthy and fresh every day. Characteristics: reduces the appearance of imperfections and pimples intensively hydrates and improves skin texture gently exfoliates and evens out skin tone smooths fine lines and wrinkles has a light consistency, quickly absorbed suitable for all skin types and shades Results of testing: 74% noted reduced blemishes 76% reported that their skin was brighter and more radiant 69% observed their skin had a more balanced tone → clinical study (self-assessment), 81 people, results after 7 days of use twice a day 93% said their skin looked fuller → clinical study, 42 people, results after 56 days of use twice a day Ingredients: azelaic acid – exfoliates skin and reduces acne scars salicylic acid – promotes cell renewal, clears clogged pores, reduces the visibility of spots hyaluronic acid – hydrates and smooths your skin, improves its texture, reduces the occurrence of fine lines and wrinkles dermatologically tested How to apply: Apply one pump of Effaclar A.Z. gel cream in the morning and evening to your clean skin (after having used a cleanser and serum). In the morning, follow up with a SPF cream which protects your skin from sun radiation. Avoid contact with eyes.
Keep up on latest news and offers. Subscribe to our newsletter.